Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:522 (8 March), doi:10.1136/bmj.39507.396644.80
| The first 150 words of the full text of this article appear below. |
Yet another tedious BMJ article on the "evils" of the drug industry.1 Perhaps the BMJ should start to focus on wider aspects of conflict of interest, such as pharmaceutical advisers peddling the verdicts of the National Institute for Health and Clinical Excellence—which itself bows to a government remit to contain cost—or to academic departments only publishing positive data to bolster research assessment exercise ratings and secure future grants. Conflicts of interest abound in modern medicine, and laying all the problems at the door of the drug industry seems to be missing the point—or perhaps the BMJ goes out of its way to "industry bash" to make itself feel less guilty about accepting industry advertising money.
Highly qualified medical professionals should not see themselves as hapless victims of a marketing machine, they should simply get smart and trained in how to manage the interface with commercial partners. It is a scandal
Hari Singh, general practitioner
1 Clare Road Surgery, Cardiff CF11 6RW
harisingh41@hotmail.com